Prescribing Information
PATIENT SITE
DARZALEX
FASPRO
®
DOSING & ADMINISTRATION GUIDE
DARZALEX
®
DOSING & ADMINISTRATION GUIDE
GET IN TOUCH
PRODUCT USE
INDICATIONS AND DOSING
Newly Diagnosed
DRd
DVMP
DVTd
Relapsed or Refractory
DRd
DPd
DKd
DVd
Monotherapy
NCCN RECOMMENDATIONS
ADMINISTRATION
CLINICAL TRIALS
DRd: MAIA
DARZALEX
FASPRO
®
: COLUMBA
ADDITIONAL TRIALS
RESOURCES
PRACTICE SUPPORT
PATIENT SUPPORT
MECHANISM OF ACTION
GET IN TOUCH
Q&A
FOR APP
s
AND NURSES
PRESCRIBING INFORMATION
DARZALEX
FASPRO
®
Prescribing Information
DARZALEX
FASPRO
®
la información de prescripción
DARZALEX
®
Prescribing Information
Important Safety Information
DARZALEX
FASPRO
®
Important Safety Information
DARZALEX
®
Important Safety Information
Contact Us
1-800-JANSSEN
Email Medical Information Center
Search Janssen MD
CONTACT US
Dosing & Administration Guide
DARZALEX
FASPRO
®
Dosing & Administration Guide
DARZALEX
®
Dosing & Administration Guide
PATIENT SITE
JANSSEN MYELOMA TREATMENTS
For US Healthcare Professionals
404 ERROR
Home
404 Error
Page not found